A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers

Stem Cells

Volumn 24, Issue 10, 2006, Pages 2220-2231

  Guo, Ke Tai ^a   Schäfer, Richard ^b   Paul, Angela ^a   Gerber, Annika ^b   Ziemer, Gerhard ^a   Wendel, Hans P ^a,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NONE   (Germany)

Author keywords

Aptamer; Fluorescence activated cell sorting analysis; Mesenchymal stem cells

Indexed keywords

APTAMER; BETA1 INTEGRIN; CD45 ANTIGEN; CELL SURFACE MARKER; DNA; FLUORESCEIN ISOTHIOCYANATE; HERMES ANTIGEN; LIGAND; STREPTAVIDIN; THY 1 ANTIGEN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE DEVELOPMENT; BONE MARROW; CELL ADHESION; CELL CLONE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; DNA PROBE; FLOW CYTOMETRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; SEQUENCE ANALYSIS; STEM CELL MOBILIZATION; SWINE;

ANIMALS; APTAMERS, NUCLEOTIDE; BONE MARROW; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; FLOW CYTOMETRY; MESENCHYMAL STEM CELLS; REPRODUCIBILITY OF RESULTS; SWINE;

SUIDAE;

EID: 33749512390     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0015     Document Type: Article

References (31)

1. Quirici N, Sologo D, Bossalasco P et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2005;30:783-791.
2. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
3. Javazon EH, Colter DC, Schwarz EJ et al. Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. STEM CELLS 2001;19:219-225.
4. Owen ME. The marrow stromal cell system. In: JN Beresford, ME Owen, eds. Marrow Stromal Cell in Culture. Cambridge, UK: Cambridge University Press, 1988:88-110.
5. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-274.
6. Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000;2:477-488.
7. Logeart-Avramoglou D, Anagnostou F, Bizios R. Engineering bone: Challenges and obstacles. J Cell Mol Med 2005;9:72-84.
8. Wilson DS, Szostak JW. In vitro selection of functional nucleic acids. Annu Rev Biochem 1999;68:611-647.
9. Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: An emerging class of therapeutics. Annu Rev Med 2005;56:555-583.
10. Brody EN, Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol 2000;74:5-13.
11. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-510.
12. Lee JH, Canny MD, De Erkenez A et al. A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. Proc Natl Acad Sci U S A 2005;102:18902-18907.
13. Ponomarev I, Becker S, Stoll T et al. Preliminary results of enhanced osteogenesis by Fibrogammin and mesenchymal stem cells on chronOS cylinders. Eur Cells Materials 2003;5:80.
14. Jaiswal N, Haynesworth SE, Caplan AI et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997;64:295-312.
15. Blank M, Weinschenk T, Priemer M et al. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. J Biol Chem 2001;19:16464-16468.
16. Daniels DA, Chen H, Hicke BJ et al. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A 2003;100:15416-15421.
17. Eder P, DeVine R, Dagle J et al. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 30 exonuclease in plasma. Antisense Res Dev 1991;1:141-151.
18. Le Blanc K, Pittenger M. Mesenchymal stem cells: Progress toward promise. Cytotherapy 2005;7:36-45.
19. Kassem M. Mesenchymal stem cells: Biological characteristics and potential clinical applications. Cloning STEM CELLS 2004;6:369-374.
20. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Cir Res 2004;95:9-20.
21. Colter DC, Class R, DiGirolamo CM et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000;97:3213-3218.
22. Tropel P, Noel D, Platet N et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2004;295:395-406.
23. Petite H, Viateau V, Bensaid W et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963.
24. White RR, Shan S, Rusconi CP et al. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A 2003;100:5028-5033.
25. Stadtherr K, Wolf H, Lindner P. An aptamer-based protein biochip. Anal Chem 2005;77:3437-3443.
26. Nimjee SM, Rusconi CP, Harrington RA. The potential of aptamers as anticoagulants. Trends Cardiovasc Med 2005;15:41-45.
27. Huang CC, Huang YF, Cao Z et al. Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal Chem 2005;77:5735-5741.
28. So HM, Won K, Kim YH et al. Single-walled carbon nanotube biosensors using aptamers as molecular recognition elements. J Am Chem Soc 2005;127:11906-11907.
29. Fitter S, James R. Deconvolution of a complex target using DNA aptamers. J Biol Chem 2005;280:34193-34201.
30. Blank M, Blind M. Aptamers as tools for target validation. Curr Opin Chem Biol 2005;9:336-342.
31. Dey AK, Griffiths C, Lea SM et al. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. RNA 2005;11:873-884.